The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, according to a ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

Shemar Moore is crediting fatherhood with “saving” him after the death of his mother in 2020. Less than three years after ...